SmithKline Beecham
This article was originally published in The Tan Sheet
Executive Summary
Jack Ziegler, exec VP, Consumer Healthcare, to president, Consumer Healthcare, and Manfred Scheske, general manager and VP, Consumer Healthcare-Germany, Austria and Switzerland, to president, Consumer Healthcare U.S., reporting to Ziegler, SB announces May 15. Ziegler has been with SB since 1991, when he joined as president, consumer brands-U.S. after 12 years at J&J, where his posts included president of personal care products. At SB, Ziegler has overseen the introduction of OTC Tagamet HB and Nicorette. He has been exec VP since 1996. While at J&J, Ziegler was "one of the original strategists behind the rapid rise of Tylenol," SB noted at the time he joined the firm. Scheske has been with SB since 1985. The company also appoints Howard Pien president of pharmaceuticals, a post that had been vacant, and Pien is succeeded as president pharmaceuticals-North America by David Stout, currently senior VP and director sales and marketing-U.S...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning